- Bank Leumi’s net income for the fourth quarter was 1.83 billion shekels.
- This is a decrease of 21% compared to the same period last year, where it was 2.33 billion shekels.
- The bank’s net interest income increased by 2% year on year, totaling 3.85 billion shekels.
- The provision for loan losses was significantly higher this year, at 668 million shekels compared to 313 million shekels the previous year.
- The bank’s performance has been positively rated, with 6 buys and no holds or sells.
A look at Bank Leumi Le-Israel BM Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 5 | |
| Resilience | 5 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 4.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Bank Leumi Le-Israel BM, one of the leading banks in Israel, has a promising long-term outlook according to the Smartkarma Smart Scores. These scores, ranging from 1 to 5, indicate the overall outlook for the company based on different factors. For Bank Leumi Le-Israel BM, the scores are all above average with a value score of 4, dividend score of 4, growth score of 5, resilience score of 5, and momentum score of 3.
With a strong focus on attracting deposits and offering a wide range of banking and financial services, Bank Leumi Le-Israel BM has established itself as a trusted and reliable institution in the Israeli market. The bank not only provides consumer loans and mortgages, but also offers insurance, mutual funds, and merchant banking services. Additionally, Bank Leumi has investments in several non-financial corporations in Israel, further diversifying its portfolio. With such a solid foundation, the high scores on the Smartkarma Smart Scores bode well for the bank’s future growth and success.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
